Trial Profile

A Multicenter, Randomized, Open-Label, Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran When Added to Pregabalin in the Treatment of Fibromyalgia.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 14 Apr 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Milnacipran (Primary)
Indications Fibromyalgia
Focus Therapeutic Use
Sponsors Forest Laboratories

Most Recent Events

16 Apr 2011 Results reporting treatment effects on cognitive function presented at the 63rd Annual Meeting of the American Academy of Neurology.
16 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
08 Nov 2010 Results presented at 74th Annual Scientific Meeting of the American College of Rheumatology and the 45th Annual Meeting of the Association of Rheumatology Health Professionals, Nov 1020

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com